Display Settings:

Format

Send to:

Choose Destination
    Bioorg Med Chem Lett. 2007 Aug 15;17(16):4464-70. Epub 2007 Jun 8.

    Identification of a novel series of benzimidazoles as potent and selective antagonists of the human melanocortin-4 receptor.

    Source

    Department of Medicinal Chemistry, Ipsen Research Laboratories, Institut Henri Beaufour, 5 Avenue du Canada, 91966 Les Ulis Cedex, France. lydie.poitout@ipsen.com

    Abstract

    A novel series of benzimidazoles was identified and optimized, leading to the discovery of potent and selective antagonists of the human melanocortin-4 receptor. In addition, compound 5i was shown to cross the blood-brain barrier after intravenous dosing in rats.

    PMID:
    17574418
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk